This systematic review provides a comprehensive review of observational and RCT-based studies of people with type 2 diabetes specifically examining heterologous treatment effects for SGLT2i and GLP1-RA therapies on glycaemic, cardiovascular, and renal outcomes. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.